Study aim: To evaluate the relationships between circulating adiponectin and FFA, and other biochemical variables (glycerol, glucose and insulin) in young, healthy non-obese men and women. Material and methods: A group of 53 male and 54 female students participated in the study. The following compounds were determined in plasma: free fatty acids (FFA), glucose and glycerol (colorimetrically), and insulin and adiponectin (by immunoassay). Insulin resistance index (HOMA-IR) was calculated from fasting insulin and glucose concentrations. Results: Mean plasma glucose was slightly lower (p<0.01), and plasma insulin and HOMA-IR markedly higher (p<0.01 -0.001) in female than in male subjects. Percent body fat was positively correlated with plasma FFA in both groups (p<0.01), but with plasma glycerol (p<0.001) in female students only. Plasma adiponectin was negatively correlated with percent body fat (p<0.02), plasma glycerol (p<0.001) and FFA (p<0.05) in female subjects only. Conclusions: Gender-related differences in body fat may affect the relationship between adiponectin and indices of lipid metabolism.
Introduction
There is a wealth of studies indicating significant sexual dimorphism in neuroendocrine and metabolic responses to various physiological stressors. In women, both fasting and insulin-induced hypoglycaemia results in reduced counter-regulatory hormonal responses and lower endogenous glucose production as compared with men [11, 14] . Marked sex-related differences were also noted in metabolic responses to prolonged dietary restriction, females being characterised by a greater body fat loss, more pronounced disturbances in sex hormone secretion and greater elevation of plasma cortisol levels than males [27] .
Males and females also differ with respect to metabolic responses to exercise. In females, a single prolonged exercise results in greater lipolytic activity and FFA utilisation than in males [3, 30] . In addition, during endurance exercise, female subjects utilise more intramuscular lipids than males [34] . Similarly, sex-related differences have been noticed in muscle responses to sprint exercise; women utilised much less glycogen as the energy source than men and their ATP recovery during a repeated bouts of sprint exercise was faster [16, 17] . Moreover, males and females substantially differ with respect to the glucoregulatory responses to exercise. Following both intense exercise (14 min at 88% ‡O 2 max) and all-out 30 s test, hyperglycaemia in females is much greater than in males resulting in higher circulating insulin and, in consequence, in a more efficient glycogen resynthesis [26, 38] .
Due to greater body fat stores in lean females than in males, there is a pronounced sex-related difference in circulating adipokines that markedly affect metabolic processes [20] . Numerous studies focused recently on metabolic functions of adiponectin, a 30 kDa protein, synthesised and secreted almost exclusively by adipocytes with higher adiponectin gene expression and protein content in subcutaneous than in the visceral fat [41] .
The most important role of adiponectin, i.e. the metabolic control of carbohydrate and lipid metabolism, has been well documented. Administration of adiponectin to mice alleviated diet-induced fatty liver [43] and in human serum the concentrations of adiponectin were positively correlated with those of circulating HDL-cholesterol and negatively with triacylglycerol [10, 21] .
Further studies revealed that adiponectin concentrations in plasma were inversely correlated with hepatic lipase activity, thus affecting HDL-cholesterol plasma levels [35] . Moreover, circulating adiponectin was found to be negatively correlated with markers of cholesterol synthesis and positively with those of cholesterol absorption [18] . It was further found to stimulate in vitro GLUT-4 translocation and glucose uptake into the muscle and to improve glucose utilisation and tolerance in vivo [8, 31] .
Circulating adiponectin is low in obese subjects, especially in the insulin-resistant ones; this is known to induce unfavourable lipoprotein profiles, insulin resistance and, in consequence, to increase the risk of atherosclerotic disease [23, 36, 40] . It is worth noting that adiponectin is under hormonal control in circulation but not in body fat. Both in vitro and in vivo studies revealed that adiponectin synthesis and its secretion from adipocytes was stimulated by insulin and leptin but inhibited by β-adrenoceptor agonists [9, 12, 13] . Moreover, an inverse relationship has been noted between circulating IL-6 and adiponectin, and between IL-6 and adiponectin m-RNA expression in adipose tissue in vitro, thus suggesting that endogenous pro-inflammatory cytokines may inhibit adiponectin synthesis [7] . In addition, adiponectin concentration in plasma increases in response to elevated plasma thyroid hormone concentrations; the biological significance of that remains, however, unknown [32] .
Despite the abovementioned reports, not all factors affecting circulating adiponectin have been fully elucidated. For example, the association between circulating adiponectin and free fatty acids (FFA) remains controversial. Bernstein et al. [2] noted that inhibition of lipolysis and decreased plasma FFA bring about similar decrease in plasma adiponectin concentration. Also Krzyża-nowska et al. [24] reported that acute elevations in plasma FFA levels were accompanied by higher circulating adiponectin. In contrast, Dullart et al. [15] found no effect of the changes in circulating adiponectin in response to fluctuations in FFA plasma concentration. Considering the gender-related differences in body fat content, it might be presumed that it affects the relationship between circulating adiponectin and FFA. Thus, this study aimed at assessing the relationship between circulating adiponectin and FFA, as well as between adiponectin and other biochemical variables (glycerol, glucose and insulin) in young, healthy non-obese men and women.
Material and Methods
Subjects: A group of 53 male and 54 female physical education students volunteered to participate in the study.
All the participants were healthy, non-smokers, not taking regularly any vitamin and/or mineral supplements, not engaged in competitive sports. All subjects submitted their written consents after having been informed about study objective and protocol, the study being accepted by the local Ethics Committee.
Methodology: The following measurements were conducted: body mass and height using a standard anthropometer and medical scales, the accuracies amounting to 0.1 cm and 0.1 kg, respectively; the thickness of 3 skinfolds (abdominal, subscapular, triceps) was determined twice using Harpenden caliper (United Kingdom), average values being used for the calculation of body fat [33] . The subjects were requested to declare the volume of their weekly physical activities (h/week).
Blood was withdrawn into heparinised tubes from the antecubital vein in the preprandial state in the morning and centrifuged for 15 min at 4000 rpm, 40 C. Plasma was stored at -70 0 C until assayed. Free fatty acids (FFA), glucose and glycerol were determined in plasma colorimetrically using commercial kits (Randox Laboratories, U.K.), commercial immunoassay kits were used to determine insulin (BioSource, Belgium) and adiponectin (DRG, Germany). The within-and between-assay errors for insulin were 2.2 and 6.5%, respectively. The sensitivity of adiponectin determination was 2 ng/ml. Insulin resistance index (HOMA-IR) was evaluated by homeostasis assessment model from fasting insulin (µIU·ml -1 )
and glucose (mmol·L -1 ) concentrations (insulin × glucose/22.5) [29] . Data analysis: Shapiro-Wilk's test was used to assess the distributions; all variables except glucose proved skewed. Prior to computing the Pearson's correlation coefficients, all non-normally distributed variables were transformed to logarithms. Statistica 7.1 software (StatSoft, Inc. USA) was used in data analysis, the level of p≤0.05 being considered significant.
Results
Somatic characteristics of the participants are presented in Table 1 . Despite the significant (p<0.001) difference in body fat content, the reported weekly volumes of motor activities were in both groups alike. Regarding the biochemical variables (Table 2) , mean plasma glucose concentration in female students was slightly but significantly (p<0.01) lower than in the male ones. In contrast, insulin levels in women were markedly higher than in men (by 31%; p<0.001). In consequence, insulin resistance index (HOMA-IR) in female participants was significantly higher than in the male ones (by 28%; p<0.001). There were no significant differences between men and women with respect to plasma FFA concentrations; however, a tendency towards a higher plasma glycerol in women than in men was noted (by 12%; p=0.06). Mean plasma adiponectin concentration was significantly lower in women than in men (by 28%; p<0.01). Percent body fat was positively correlated with plasma FFA in both groups (p<0.01), but with plasma glycerol (p<0.001) in female students only (Table 3) . Plasma adiponectin was negatively correlated with percent body fat (p<0.02; Table 3 ), plasma glycerol (p<0.001) and FFA (p<0.05) in female subjects only (Table 4) . 
Discussion
Our study confirmed other reports on a higher insulin resistance in female than in male subjects [1, 39] and on higher plasma glycerol levels in women than in men due to lower density of α-adrenoceptors and higher that of β-adrenoceptors in adipose tissue of females than of males [42] . Additionally, our study revealed that in females both plasma glycerol and FFA were positively associated with percent of body fat -the major source of those compounds in plasma [5] . In young male subjects, their body fat (relative content) affected exclusively circulating FFA with no effect on plasma glycerol levels. However, the reason for the lack of associations between plasma glycerol and body fat could be only speculated. It is well known that under fasting conditions glycerol is taken up by the liver for gluconeogenesis [4] . On the other hand, there are data indicating more efficient de novo glucose production in male than in female subjects [19, 22] . Thus, it seems feasible that plasma glycerol levels in men are to a greater extent affected by liver uptake than in women resulting in disappearance of a simple relationship with body fat stores.
Lower plasma adiponectin levels in women than in men reported in this study may be due not only to higher body fat stores but also to lower testosterone levels in females than in males [6, 37] and, in addition, the relationship between plasma adiponectin and other biochemical variables was found in this study only in women. These findings do not rule out a contribution of adiponectin to the regulation of carbohydrate and lipid metabolism, mentioned in the introduction, or of body fat on circulating adiponectin in males, because detecting such effects may require a deeper multivariate analysis. Moreover, Martin et al. [28] reported that the relationships of adiponectin with selected metabolic variables were weak in lean subjects but progressed with increasing adiposity and Lavoine et al. [25] suggested that the relationship between plasma adiponectin and FFA indirectly reflected an association between circulating adiponectin and body fat.
Summing up, our study revealed that in contrast to women, neither body fat nor circulating FFA affected plasma adiponectin levels in young, lean men. Thus, it seemed that the gender-related differences in body fat may affect the relationship between adiponectin and indices of lipid metabolism.
